RHYTHM PHARMACEUTICALS, INC.·4

Feb 16, 5:27 PM ET

Stewart Murray 4

4 · RHYTHM PHARMACEUTICALS, INC. · Filed Feb 16, 2021

Insider Transaction Report

Form 4
Period: 2021-02-11
Stewart Murray
Chief Medical Officer
Transactions
  • Award

    Restricted Stock Units

    2021-02-11+9,3759,375 total
    Common Stock (9,375 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-02-11+56,25056,250 total
    Exercise: $30.66Exp: 2031-02-10Common Stock (56,250 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
  • [F2]The restricted stock units vest as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date
  • [F3]The stock options were granted on February 11, 2021. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.

Documents

1 file
  • 4
    tm216849-3_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT